NJ-DMDG

Drug Met Symposium and Vendor Show

                [ back ]
Date:   April 14, 2016
Venue: The Palace at Somerset Park, 333 Davidson Avenue, Somerset, NJ 08873.

Mark your calendars for The North Jersey Drug Metabolism Discussion Group Spring 2016 Symposium and Vendor Exhibition, to be held at The Palace at Somerset Park, 333 Davidson Avenue, Somerset, NJ 08873, on Thursday, April 14, from 8:00-4:00 PM.

Registration Information:

Pre-registration fee is $125 (pre-register by 7 April 2016).

Registration fee at the door is $150 (Checks only)

Registration fee is $10 for students and postdocs and $50 for faculty

Registration is free for unemployed

Please plan to pre-register as a group, as coordinated by a member of the NJACS DMDG steering committee from your organization (see list).

  • If you have no DMDG member at your company, please contact Richard Lauren Aleksunes       (aleksunes@eohsi.rutgers.edu) for registration.
  • Payments by personal or company checks.  Sorry, credit cards are not accepted.
  • Checks should be made payable to: NJ Drug Metabolism Discussion Group.

Exhibitors:

2016 Spring Symposium and Vendor Exhibition

Sponsored by the

North Jersey ACS

Drug Metabolism Discussion Group

“Transforming assessment of Drug Disposition with Novel Methodologies”

The Palace at Somerset Park, 333 Davidson Avenue Somerset, New Jersey

14 April, 2016 8:00 am – 4:00 pm

Program

“Transforming assessment of Drug Disposition with Novel Methodologies”

8:00 a.m.

Registration / Continental Breakfast / Vendor Exhibit

9:00 a.m.

Introductory Remarks

Lauren Aleksunes, Chair, NJDMDG

9:10 a.m.

Topic:  Application of Engineered Mouse Models for Xenobiotic Disposition Studies

Xinxin Ding, SUNY Polytechnic Institute

10:00 a.m.

Topic:  Challenges in Identifying Biomarkers for Transporter-Mediated Drug-Drug Interactions in Liver and Kidney

Raymond Evers, Merck & Co.

10:45 a.m.

Vendor Exhibit & Coffee Break

11:30 p.m.

Topic: Microsampling in Nonclinical Studies: Where are We Now?

Laura Patrone, Bristol-Myers Squibb

12:15 p.m.

Lunch & Vendor Exhibit

1:45 p.m.

Topic: MALDI Imaging MS: Seeing Drug ADME in Tissues at Last

Stephen Castellino, GlaxoSmithKline

2:30 p.m.

Vendor Exhibit & Coffee Break

3:00 p.m.

Topic: Validation of an Integrated Series of Ligand Binding Assays for the Quantitative Determination of Antibody Drug Conjugates in Biological Matrices

Heather Myler, Bristol-Myers Squibb

3:45 p.m.

Program Closure